Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	View
JXSL2200114	注射用重组人凝血因子IX-白蛋白融合蛋白	Lyophilized	Biological Products(3.1)	Import Drug Application	2022-07-11	Parexel China Co Ltd;Csl Behring GmbH	view
JXSL2200117	注射用重组人凝血因子IX-白蛋白融合蛋白	Lyophilized	Biological Products(3.1)	Import Drug Application	2022-07-11	Parexel China Co Ltd;Csl Behring GmbH	view
JXSL2200116	注射用重组人凝血因子IX-白蛋白融合蛋白	Lyophilized	Biological Products(3.1)	Import Drug Application	2022-07-11	Parexel China Co Ltd;Csl Behring GmbH	view
JXSL2200118	注射用重组人凝血因子IX-白蛋白融合蛋白	Lyophilized	Biological Products(3.1)	Import Drug Application	2022-07-11	Parexel China Co Ltd;Csl Behring GmbH	view
JXSL2200115	注射用重组人凝血因子IX-白蛋白融合蛋白	Lyophilized	Biological Products(3.1)	Import Drug Application	2022-07-11	Parexel China Co Ltd;Csl Behring GmbH	view